Pluripotency of mesenchymal stem cells derived from adult marrow
By Yuehua Jiang, B. Jahagirdar, R. Reinhardt, R. Schwartz, C. Keene, Xilma R. Ortiz-González, M. Reyes, T. Lenvik, T. Lund, M. Blackstad and 6 more. Nature, 2007
3,099 citations recorded by the source corpus.
Subfields: Genetics, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/f599f666c269578b36dff554dc0b5e0e1a0c5c7c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- A. Caplan
- Chaomei Chen
- Lorraine O'Driscoll
- T. Suda
- Frank Barry
- S. Yamanaka
- P. Vader
- B. W. van Balkom
In Pulmonary and Respiratory Medicine
In Surgery
Citations in the corpus
- Pluripotency: Toward a gold standard for human ES and iPS cells (2009, background): “However, the attempts to produce chimeric mice by injection into blastocysts (Jiang et al., 2002) did not produce compelling evidence that the cells contributed to organ or tissue formation and the cells do not form teratomas upon injection into immunodeficient mice.”
- Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace (2012, background): “, entitled Pluripotency of mesenchymal stem cells derived from adult marrow [25].”
- Stem cell plasticity: time for a reappraisal? (2005, neutral): “Recently, a third source of liver-repopulating cells has proven to be the BM. Petersen et al.46 transplanted syngeneic male BM cells into lethally irradiated female recipient rats that had been treated with 2-acetylaminofluorene, to inhibit hepatocyte proliferation, and then received hepatic injury ”
- Mesenchymal stem cells avoid allogeneic rejection (2005, background): “The diversity of characteristics associated with MSC can be explained by differences in tissue origin, isolation methods and culture conditions between laboratories, in addition there appear to be strain-to-strain differences in murine derived MSC[2,7-9].”
- Emerging trends and new developments in regenerative medicine: a scientometric update (2000 – 2014) (2014, neutral): “(2002) NATURE, V418, P41 [43] 255.”
- Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies (2007, background): “, 2002) and that they “had phenobarbital-inducible cytochrome P450” (Jiang et al., 2002).”